Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-11

Clinical Trial Update: Assessment and Tracking of Long-term Alefacept Safety

View source ↗

Summary

This clinical trial update reports on long-term safety monitoring for alefacept in psoriasis and notes that the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amevive (alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Psoriasis | Status: TERMINATED